Industry News

Breakthrough Therapy Designation further supports the differentiated clinical profile of CLN-081. Click link below to read press release. Source: https://investors.cullinanoncology.com/news-releases/news-release-details/fda-grants-breakthrough-therapy-designation-cullinan-oncologys

Of the top 50 fastest-growing public companies in MA, 72% of them are Life Sciences companies. We’re proud to see 10 of our current clients on this list, further fueling our confidence that the Biotech sector will be the catalyst for economic recovery in the second half of 2020. Life science companies continue to be […]

While Massachusetts is one of several “hot spots” of Covid-19 cases, it is also the epicenter of potential solutions. From diagnostics to therapies to, ultimately, a vaccine – our Massachusetts Biotech community will have a consequential role in ensuring brighter days lie ahead! #covid19 #therapies #drugdevelopment #clinicaltrial #biotechnologyindustry We are currently living through a historic […]

Great article on covid-19 and its impact on the Biotech industry. I am particularly interested to see if the many (most) companies that are implementing interim remote-work arrangements will eventually consider this as part of their long-term/permanent strategy. This would be of enormous impact in helping to ease the supply/demand conditions that are so pervasive, […]

Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma | Business Wire Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Source: Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma […]

BOS/CAMB is the undisputed capital of the Biotech/Pharmaceutical industry, and this is a terrific opportunity to hear directly from heads-of-industry as to why that is! Join the BBJ for our last Power Breakfast of 2019 as we discuss the business of biotech and the life sciences of the Boston area. Source: Power Breakfast: Life Sciences […]

Female representation in the C-suite has grown to 21%-up from 17% in 2015. Better…but plenty of room for improvement. Seeing this list makes us hopeful that pharma/biotech will continue lead the march towards a level of parity that is desperately needed! More women have climbed to the top of the corporate ladder than ever before. […]

Cambridge with another strong showing this year, home to nearly half the winners! This has been the year of the preclinical biotech cash out: So many early-stage, promising young startups have gone public earlier than ever before or sold to an opportunistic pharma. Plenty of private, independent biotechs are still out there, though—and here are […]

As many industries start to feel a slow down in pace as we hit the peak of summer, the Genetown Biotech scene never sleeps! Submissions, approvals, and hiring continues to push forward during these warmer months. Check out some updates on local news that you may have missed! Even with a holiday week, July 4, […]

With companies like Beigene pioneering the road for intercontinental operations, a new trend has emerged – overseas biotechs, particularly many Chinese based companies, are growing US based satellite offices and tapping into local talent. Though the cost of labor is exponentially higher, the US market and approval process may outweigh the costs. What are your […]